News

A research team has examined the use of high-intensity focused ultrasound as a non-invasive cancer treatment that works by targeting acoustic waves to destroy cancer cells. The study was published in Bulletin of Mathematical Biology.

The NHS will today launch the world’s largest trial of a revolutionary new blood test that can detect more than 50 types of cancer before symptoms appear.

A team of scientists shows that treatment with AHR agonists decreases expression of ACE2 via AHR activation, reducing the ability of SARS-CoV-2 to enter the cell.

Researchers have been awarded a grant to launch a new Center of Excellence in Therapeutics (CET). The CET will study the effects of medications on human milk and infant health.

Probenecid, a drug used to treat gout, has been shown to possess broad antiviral properties, making it a prime candidate to combat SARS-CoV-2 infection as well as other common respiratory viruses.

Columbia University Irving Medical Center, its Herbert Irving Comprehensive Cancer Center, and Pfizer Inc. have established the Columbia–Pfizer Clinical Trials Diversity Initiative. The initiative's aim is to reduce health disparities by increasing the participation of underrepresented minorities in clinical studies and enhancing the diversity of clinical researchers.

An antioxidant drug has been shown to reverse atherosclerosis. The Journal of the American Heart Association study suggests that the drug could be used to prevent heart attacks and strokes due to clots.

A new study by UT Southwestern scientists indicates that an enzyme called protein phosphatase 2 (PP2A) appears to be a major driver of preeclampsia, a dangerous pregnancy complication characterized by the development of high blood pressure and excess protein in the urine.

A new study by researchers at the University of Manchester suggests that existing FDA-approved drugs may be suitable for repurposing as prophylactics, or for use in combination with vaccine therapy, to ward off COVID-19.

A new study published in Nature reports that common medications can accumulate in gut bacteria. The accumulation can alter the normal functioning of the bacteria and has the potential to reduce the medications’ effectiveness.